Medicines Co
MDCO
MDCO was delisted on the 3rd of January, 2020.
203 hedge funds and large institutions have $2.8B invested in Medicines Co in 2019 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 76 increasing their positions, 55 reducing their positions, and 21 closing their positions.
76% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 21
51% more capital invested
Capital invested by funds: $1.85B → $2.8B (+$950M)
38% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 55
8% more funds holding
Funds holding: 188 → 203 (+15)
5.3% more ownership
Funds ownership: 144.7% → 150.01% (+5.3%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
15% less call options, than puts
Call options by funds: $145M | Put options by funds: $170M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$36.8M |
| 2 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
+$20.2M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
+$16.2M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$15.3M |
| 5 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$12.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$50.1M |
| 2 |
BlackRock
New York
|
-$18.9M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$8.27M |
| 4 |
BM
Bridger Management
New York
|
-$5.16M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.68M |
MDCO Hedge Fund Activity: Q1 2019 in Review
203 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q1 2019, worth a combined $2.8B — up 51% from $1.85B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new MDCO positions and 21 closed out — a net gain of 16 holders — while 76 added to existing stakes and 55 trimmed.
The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $36.8M. The largest seller was HealthCor Management, cutting an estimated $50.1M.
- 203 institutional investors held Medicines Co (MDCO) as of Q1 2019, up from 188 in Q4 2018.
- Funds reported $2.8B of Medicines Co stock for Q1 2019, up 51% quarter-over-quarter.
- 37 funds opened new Medicines Co positions in Q1 2019 and 21 closed out, a net change of +16 holders.
- The largest Medicines Co buyer in Q1 2019 was Avoro Capital Advisors, an estimated $36.8M added.
- The largest Medicines Co seller in Q1 2019 was HealthCor Management, an estimated $50.1M sold.
Based on aggregated 13F filings for Q1 2019.